Britain Announces Coronavirus Vaccine Ready in June! Research into treatments and vaccines for the novel coronavirus continues intensively around the world. Every country has mobilized resources to overcome the pandemic. Today comes encouraging news from the UK, where scientists have been working rapidly on both prevention and treatment. Oxford University and the pharmaceutical company AstraZeneca announced a partnership to develop a vaccine against the coronavirus. Clinical trials are ongoing, and officials say the vaccine could be ready in June if trials confirm its effectiveness.
Oxford University, one of the UK’s leading institutions, stated it has reached an agreement with AstraZeneca to accelerate the candidate coronavirus vaccine currently in trials toward widespread use. In a written statement, Oxford noted that development and clinical testing are continuing, and that manufacturing will begin immediately once the vaccine’s full effectiveness and safety are established.
No Profit Will Be Sought from Vaccine Production
No Profit Will Be Sought from Vaccine Production. According to the joint announcement from Oxford University and AstraZeneca, if the vaccine proves successful it will be made accessible globally. The partners emphasized plans to work with international organizations to ensure rapid distribution to low- and middle-income countries. Both parties said they will not aim to make a profit from production; pricing will cover only manufacturing and distribution costs.
Separately, Oxford medical professor Sir John Bell commented that the partnership with AstraZeneca will be a significant asset in combating epidemic diseases in the coming years. He added that once the candidate vaccine receives approval, they will be in a strong position to fight the coronavirus. Results from clinical trials are expected to be clarified by June, and if outcomes are positive production will commence immediately.